uniQure Pharma (QURE) Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

uniQure Pharma (QURE) korporativ emblemasi va logotipi

uniQure N.V. formula ishlab chiqish va sinovlarini tashqi pudratchilarga topshirish orqali o'zining ilmiy tadqiqotlarini optimallashtirmoqda. Foyda nisbatidagi narx baholovi ushbu strategiyani tasdiqlaydi, bunda ko'rsatkich hozirda -7.00 darajasida turibdi. Kompaniya modulli AAV platformasi va o'zining ichki imkoniyatlariga tayanadi. O'sish istiqbollari jigar va markaziy nerv tizimi davolash usullarini sinov bosqichidan bozorga o'tkazish bilan bog'liq.

uniqure.com (QURE): Narxning foydaga nisbati 04.07.2022dan 16.11.2026gacha

uniQure N.V. (QURE) kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning har tomonlama tahlili:uniQure Corp QURE
uniQure Pharma original mahsuloti

uniQure N.V. (QURE) kompaniyasining gen terapiyasi sohasidagi yutuqlari va gemofiliya davolash bo'yicha sherikliklari kompaniyaning joriy bozor P/E koeffitsiyentida aks etgan bo'lib, u bozor kapitalizatsiyasini sof foyda bilan solishtiradi. Ushbu koeffitsiyent bir dollar foydaning tannarxini o'lchaydi, bu esa investorlarga aktivlarning haddan tashqari qimmat baholanganlik darajasini va inflyatsiyaviy muhitda arzon, ammo samarasiz qimmatqog'ozlarni sotib olish xavfini aniqlashga yordam beradi.

Raqobatdosh kompaniyalar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati